Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-19

FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Oryza pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Bupropion Hydrochloride XL from Oryza Pharmaceuticals Inc., confirming the extended-release formulation approval…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE)